308 related articles for article (PubMed ID: 21788759)
1. Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre- and probiotics in critically ill children.
Simakachorn N; Bibiloni R; Yimyaem P; Tongpenyai Y; Varavithaya W; Grathwohl D; Reuteler G; Maire JC; Blum S; Steenhout P; Benyacoub J; Schiffrin EJ
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):174-81. PubMed ID: 21788759
[TBL] [Abstract][Full Text] [Related]
2. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial.
Vlieger AM; Robroch A; van Buuren S; Kiers J; Rijkers G; Benninga MA; te Biesebeke R
Br J Nutr; 2009 Sep; 102(6):869-75. PubMed ID: 19331702
[TBL] [Abstract][Full Text] [Related]
3. Tolerance of an enteral formula with insoluble and prebiotic fiber in children with compromised gastrointestinal function.
Khoshoo V; Sun SS; Storm H
J Am Diet Assoc; 2010 Nov; 110(11):1728-33. PubMed ID: 21034888
[TBL] [Abstract][Full Text] [Related]
4. Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding.
Magne F; Hachelaf W; Suau A; Boudraa G; Bouziane-Nedjadi K; Rigottier-Gois L; Touhami M; Desjeux JF; Pochart P
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):580-8. PubMed ID: 18493215
[TBL] [Abstract][Full Text] [Related]
5. Early enteral administration of immunonutrition in critically ill children: results of a blinded randomized controlled clinical trial.
Briassoulis G; Filippou O; Hatzi E; Papassotiriou I; Hatzis T
Nutrition; 2005; 21(7-8):799-807. PubMed ID: 15975487
[TBL] [Abstract][Full Text] [Related]
6. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study.
Roessler A; Forssten SD; Glei M; Ouwehand AC; Jahreis G
Clin Nutr; 2012 Feb; 31(1):22-9. PubMed ID: 21963389
[TBL] [Abstract][Full Text] [Related]
7. A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA.
Campeotto F; Suau A; Kapel N; Magne F; Viallon V; Ferraris L; Waligora-Dupriet AJ; Soulaines P; Leroux B; Kalach N; Dupont C; Butel MJ
Br J Nutr; 2011 Jun; 105(12):1843-51. PubMed ID: 21426607
[TBL] [Abstract][Full Text] [Related]
8. Comparison of stool microbiota compositions, stool alpha1-antitrypsin and calprotectin concentrations, and diarrhoeal morbidity of Indonesian infants fed breast milk or probiotic/prebiotic-supplemented formula.
Oswari H; Prayitno L; Dwipoerwantoro PG; Firmansyah A; Makrides M; Lawley B; Kuhn-Sherlock B; Cleghorn G; Tannock GW
J Paediatr Child Health; 2013 Dec; 49(12):1032-9. PubMed ID: 23782263
[TBL] [Abstract][Full Text] [Related]
9. Additional oligofructose/inulin does not increase faecal bifidobacteria in critically ill patients receiving enteral nutrition: a randomised controlled trial.
Majid HA; Cole J; Emery PW; Whelan K
Clin Nutr; 2014 Dec; 33(6):966-72. PubMed ID: 24290345
[TBL] [Abstract][Full Text] [Related]
10. Effect of formula composition on the development of infant gut microbiota.
Hascoët JM; Hubert C; Rochat F; Legagneur H; Gaga S; Emady-Azar S; Steenhout PG
J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):756-62. PubMed ID: 21593648
[TBL] [Abstract][Full Text] [Related]
11. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants.
Costalos C; Kapiki A; Apostolou M; Papathoma E
Early Hum Dev; 2008 Jan; 84(1):45-9. PubMed ID: 17433577
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics.
Puccio G; Cajozzo C; Meli F; Rochat F; Grathwohl D; Steenhout P
Nutrition; 2007 Jan; 23(1):1-8. PubMed ID: 17189085
[TBL] [Abstract][Full Text] [Related]
13. Physiological and bifidogenic effects of prebiotic supplements in infant formulae.
Veereman-Wauters G; Staelens S; Van de Broek H; Plaskie K; Wesling F; Roger LC; McCartney AL; Assam P
J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):763-71. PubMed ID: 21593649
[TBL] [Abstract][Full Text] [Related]
14. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study.
Bekkali NL; Bongers ME; Van den Berg MM; Liem O; Benninga MA
Nutr J; 2007 Aug; 6():17. PubMed ID: 17683583
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of selected synbiotics on the human faecal microbiota composition.
Saulnier DM; Gibson GR; Kolida S
FEMS Microbiol Ecol; 2008 Dec; 66(3):516-27. PubMed ID: 18673391
[TBL] [Abstract][Full Text] [Related]
16. Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment.
Brunser O; Gotteland M; Cruchet S; Figueroa G; Garrido D; Steenhout P
Pediatr Res; 2006 Mar; 59(3):451-6. PubMed ID: 16492988
[TBL] [Abstract][Full Text] [Related]
17. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents.
Weizman Z; Asli G; Alsheikh A
Pediatrics; 2005 Jan; 115(1):5-9. PubMed ID: 15629974
[TBL] [Abstract][Full Text] [Related]
18. Effects of probiotics on enteric flora and feeding tolerance in preterm infants.
Lee SJ; Cho SJ; Park EA
Neonatology; 2007; 91(3):174-9. PubMed ID: 17377402
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of inulin and oligofructose supplementation in infant formula: results from a randomized clinical trial.
Closa-Monasterolo R; Gispert-Llaurado M; Luque V; Ferre N; Rubio-Torrents C; Zaragoza-Jordana M; Escribano J
Clin Nutr; 2013 Dec; 32(6):918-27. PubMed ID: 23498848
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerance of the human milk probiotic strain Lactobacillus salivarius CECT5713 in 6-month-old children.
Maldonado J; Lara-Villoslada F; Sierra S; Sempere L; Gómez M; Rodriguez JM; Boza J; Xaus J; Olivares M
Nutrition; 2010; 26(11-12):1082-7. PubMed ID: 20018483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
